Tag: current

Project delivered under a US$41 million transaction as part of the 21 MW DC Honeywell portfolio in upstate New York7.01 MW DC ground-mount solar...

Environmental, health, and safety solution is part of Veeva Quality Cloud and will deliver real-time insights and streamlined workflowsPLEASANTON, Calif., June 25, 2026 /PRNewswire/...

First underground core holes intersect a late silver-gold-copper event overprinting the principal polymetallic system, including 0.70 metres (true width) grading 4,604 g/t silver at...

Beam Global is relocating manufacturing from San Diego to Yuma, Arizona, reducing costs, improving margins, and supporting future growth.

New headquarters strengthens CDS' US-based infrastructure and expands capacity for dealer support, training, engineering, fulfillment, and long-term innovationIRVINE, Calif., June 25, 2026 /PRNewswire/ --...

DEMIRE is expanding its ESG database to cover almost its entire portfolio and is continuing to drive forward decarbonization

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

RUTHERFORD, N.J., June 24, 2026 /PRNewswire/ -- Kreyco Inc., a provider of educational services to New York City public schools between 2023 and 2025,...

TORONTO, June 24, 2026 /CNW/ - Jamieson Wellness Inc. ("Jamieson" or the "Company") (TSX: JWEL) acknowledges a recent media report regarding a potential sale...

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...

SEOUL, South Korea, June 25, 2026 /PRNewswire/ -- SK keyfoundry, an 8-inch pure-play foundry in Korea, announced that it has recently developed a 'Bi-SCR...